Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
$0.56
+0.9%
$0.69
$0.50
$1.95
$5.97M1.6220,308 shs558 shs
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$0.06
+5.9%
$0.07
$0.00
$0.12
$19.37M1.7797,046 shs120,310 shs
MusclePharm Co. stock logo
MSLP
MusclePharm
$0.00
$0.00
$0.00
$7K-0.0726,442 shsN/A
Rexahn Pharmaceuticals, Inc. stock logo
REXN
Rexahn Pharmaceuticals
$2.06
$1.26
$4.26
$8.11M0.98162,968 shs2,579 shs
ULURU Inc. stock logo
ULUR
ULURU
$0.00
$0.10
$0.79
$5.35M-3.136,691 shsN/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
+1.85%-3.51%-22.54%-8.33%-53.39%
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
0.00%-13.24%-10.61%-26.25%+84.38%
MusclePharm Co. stock logo
MSLP
MusclePharm
0.00%0.00%0.00%0.00%-53.85%
Rexahn Pharmaceuticals, Inc. stock logo
REXN
Rexahn Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
ULURU Inc. stock logo
ULUR
ULURU
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/AN/AN/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
N/AN/AN/AN/AN/AN/AN/AN/A
Rexahn Pharmaceuticals, Inc. stock logo
REXN
Rexahn Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
ULURU Inc. stock logo
ULUR
ULURU
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
2.00
HoldN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
N/AN/AN/AN/A
Rexahn Pharmaceuticals, Inc. stock logo
REXN
Rexahn Pharmaceuticals
N/AN/AN/AN/A
ULURU Inc. stock logo
ULUR
ULURU
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
$10K596.63N/AN/A($2.27) per share-0.24
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$50K387.48N/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
$50.04M0.00N/AN/A($0.94) per share0.00
Rexahn Pharmaceuticals, Inc. stock logo
REXN
Rexahn Pharmaceuticals
N/AN/AN/AN/A$2.48 per shareN/A
ULURU Inc. stock logo
ULUR
ULURU
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
-$48.07M-$7.98N/AN/AN/A-3,967.23%-339.10%5/21/2024 (Estimated)
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
-$370KN/A0.00N/A5.77%20.61%11.73%N/A
MusclePharm Co. stock logo
MSLP
MusclePharm
-$12.87M-$0.58N/AN/AN/A-38.51%N/A-169.56%N/A
Rexahn Pharmaceuticals, Inc. stock logo
REXN
Rexahn Pharmaceuticals
-$8.64MN/A0.00N/AN/AN/A-72.60%-55.68%N/A
ULURU Inc. stock logo
ULUR
ULURU
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest ADXS, MSLP, ETST, REXN, and ULUR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/16/2024Q4 2023
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
N/A-$2.96-$2.96-$2.96N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
N/AN/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
N/AN/AN/AN/AN/A
Rexahn Pharmaceuticals, Inc. stock logo
REXN
Rexahn Pharmaceuticals
N/AN/AN/AN/AN/A
ULURU Inc. stock logo
ULUR
ULURU
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
N/A
0.30
0.30
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
0.10
0.87
0.39
MusclePharm Co. stock logo
MSLP
MusclePharm
N/A
0.25
0.23
Rexahn Pharmaceuticals, Inc. stock logo
REXN
Rexahn Pharmaceuticals
N/A
3.37
3.37
ULURU Inc. stock logo
ULUR
ULURU
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
7.18%
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/A
MusclePharm Co. stock logo
MSLP
MusclePharm
15.49%
Rexahn Pharmaceuticals, Inc. stock logo
REXN
Rexahn Pharmaceuticals
7.49%
ULURU Inc. stock logo
ULUR
ULURU
N/A

Insider Ownership

CompanyInsider Ownership
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
0.63%
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
24.90%
MusclePharm Co. stock logo
MSLP
MusclePharm
60.70%
Rexahn Pharmaceuticals, Inc. stock logo
REXN
Rexahn Pharmaceuticals
1.10%
ULURU Inc. stock logo
ULUR
ULURU
1.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
N/A10.75 million10.68 millionNot Optionable
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
8309.98 million232.80 millionNot Optionable
MusclePharm Co. stock logo
MSLP
MusclePharm
2733.39 million13.12 millionNot Optionable
Rexahn Pharmaceuticals, Inc. stock logo
REXN
Rexahn Pharmaceuticals
54.48 millionN/AOptionable
ULURU Inc. stock logo
ULUR
ULURU
230.57 million30.24 millionNot Optionable

ADXS, MSLP, ETST, REXN, and ULUR Headlines

SourceHeadline
Tracing 30 years of Priscilla, Queen of the Desert on our own Australian adventureTracing 30 years of Priscilla, Queen of the Desert on our own Australian adventure
uk.style.yahoo.com - April 26 at 12:51 PM
Lake Eyre Yacht Club hits rough water as state extends national park limitsLake Eyre Yacht Club hits rough water as state extends national park limits
theaustralian.com.au - April 26 at 12:51 PM
I spent a relaxing weekend in Europe and I didn’t even have to leave AustraliaI spent a relaxing weekend in Europe and I didn’t even have to leave Australia
townsvillebulletin.com.au - April 26 at 2:50 AM
Luxury travel has changed. Here’s what to expect in 2024Luxury travel has changed. Here’s what to expect in 2024
couriermail.com.au - April 26 at 2:50 AM
Bush tucker meals, truffle hunts and wine master classes: Savour the unique as you fulfil this foodie bucket listBush tucker meals, truffle hunts and wine master classes: Savour the unique as you fulfil this foodie bucket list
straitstimes.com - April 26 at 2:50 AM
Dozens of pilot whales dead after massive stranding on Western Australia beachDozens of pilot whales dead after massive stranding on Western Australia beach
yahoo.com - April 26 at 2:50 AM
Better Homes & Gardens: April 26Better Homes & Gardens: April 26
tvtonight.com.au - April 24 at 5:24 AM
AAT Kings extends Australia and New Zealand guided vacations saleAAT Kings extends Australia and New Zealand guided vacations sale
travelweek.ca - April 23 at 2:23 PM
Five great walks in the Northern TerritoryFive great walks in the Northern Territory
australiangeographic.com.au - April 23 at 9:22 AM
What a modern retirement plan should look likeWhat a modern retirement plan should look like
smh.com.au - April 21 at 7:56 AM
Aussies ‘locked out’ of national parks to protect cultural heritageAussies ‘locked out’ of national parks to protect cultural heritage
news.com.au - April 21 at 7:56 AM
The rise of booze-free backpacking: why gen Z are choosing to travel soberThe rise of booze-free backpacking: why gen Z are choosing to travel sober
theguardian.com - April 21 at 7:56 AM
Bolt: Ban on non-Aborigines is the new apartheidBolt: Ban on non-Aborigines is the new apartheid
heraldsun.com.au - April 21 at 7:56 AM
Colin and Joh explore UluruColin and Joh explore Uluru
bhg.com.au - April 19 at 7:00 PM
The 11 Best Road Trips in the WorldThe 11 Best Road Trips in the World
outsideonline.com - April 18 at 4:50 AM
Truth-telling risks inflaming community conflict: reportTruth-telling risks inflaming community conflict: report
afr.com - April 18 at 4:50 AM
It’s political spending that feeds inflation, not Coles and WooliesIt’s political spending that feeds inflation, not Coles and Woolies
afr.com - April 18 at 4:50 AM
Truth, colonisation and Yoorrook: what is Victoria’s truth-telling inquiry and what will it achieve?Truth, colonisation and Yoorrook: what is Victoria’s truth-telling inquiry and what will it achieve?
theguardian.com - April 18 at 4:50 AM
Better Homes & Gardens: April 19Better Homes & Gardens: April 19
tvtonight.com.au - April 17 at 5:32 PM
LET THE GAMES BEGIN! REVERSE: 1999 FIRES OFF AUSTRALIA-THEMED VERSION 1.5 PHASE ONE UPDATE “REVIVAL! THE ULURU GAMES” TODAYLET THE GAMES BEGIN! REVERSE: 1999 FIRES OFF AUSTRALIA-THEMED VERSION 1.5 PHASE ONE UPDATE “REVIVAL! THE ULURU GAMES” TODAY
capsulecomputers.com.au - April 16 at 9:30 PM
Miguel Maestre teams up with Tourism NT and Luxury EscapesMiguel Maestre teams up with Tourism NT and Luxury Escapes
ntnews.com.au - April 15 at 8:22 PM
‘My kids were heartbroken over Bluey’s biggest episode’‘My kids were heartbroken over Bluey’s biggest episode’
adelaidenow.com.au - April 14 at 2:03 PM
The cost of marrying a British princeThe cost of marrying a British prince
msn.com - April 14 at 2:03 PM
Former soldier returns boomerang from nuclear test era to Maralingas traditional ownersFormer soldier returns boomerang from nuclear test era to Maralinga's traditional owners
msn.com - April 14 at 2:03 PM

Media Sentiment Over Time

Company Descriptions

Ayala Pharmaceuticals logo

Ayala Pharmaceuticals

NASDAQ:ADXS
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.
Earth Science Tech logo

Earth Science Tech

OTCMKTS:ETST
Earth Science Tech, Inc. focuses on health and wellness industry. It operates men's health telemedicine platform under brand Peak name; and operates pharmacy. The company offers supplements and topicals products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.
MusclePharm logo

MusclePharm

OTCMKTS:MSLP
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
Rexahn Pharmaceuticals logo

Rexahn Pharmaceuticals

NASDAQ:REXN
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.
ULURU logo

ULURU

OTCMKTS:ULUR
ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. was founded in 1987 and is based in Addison, Texas.